Max Johnston
Follow
Get notifications in MyBN when activity occurs.
Max Johnston
Non-Executive Director, Acting Chief Executive Officer / Medical Developments International
Most Notable Role
Max Johnston has extensive overseas experience during his career in leading businesses in Western and Central-Eastern Europe and Africa as well as the Asia Pacific region.
Mr Johnston was president and chief executive of Johnson & Johnson Pacific, a division of the world’s largest medical, pharmaceutical and consumer healthcare company for 11 years. Prior to joining Johnson & Johnson, Mr Johnston’s career also included senior roles with Diageo and Unilever in Europe.
He has also held several prominent industry roles including as past president of ACCORD Australasia, vice chair of the Australian Food and Grocery Council, and former board member of ASMI.
Mr Johnston is a non-executive director of Medical Developments International and Enero Group, and non-executive chair of Probiotec.
Mr Johnston was president and chief executive of Johnson & Johnson Pacific, a division of the world’s largest medical, pharmaceutical and consumer healthcare company for 11 years. Prior to joining Johnson & Johnson, Mr Johnston’s career also included senior roles with Diageo and Unilever in Europe.
He has also held several prominent industry roles including as past president of ACCORD Australasia, vice chair of the Australian Food and Grocery Council, and former board member of ASMI.
Mr Johnston is a non-executive director of Medical Developments International and Enero Group, and non-executive chair of Probiotec.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1410th | Medical Developments International | -40% | -39% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Medical Developments International | $33.1m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEWS: Tagged in Board Moves, April 19 2024 | 19 Apr 2024 |
| NEW ROLE: Non-Executive Director, Neurotech International | 19 Apr 2024 |
| NEW ROLE: Interim Chief Executive, Polynovo | 22 Feb 2022 |
| NEWS: Tagged in AusCann to acquire animal business for $18m | 16 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Acting Chief Executive Officer, Medical Developments International | 03 Nov 2020 |
